{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T19:53:49Z","timestamp":1775073229723,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jceh.2023.03.005","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T03:29:54Z","timestamp":1679023794000},"page":"730-735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Autoantibody Positivity Has No Impact on Histological Parameters in Nonalcoholic Fatty Liver Diseases"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9489-2497","authenticated-orcid":false,"given":"Kavita","family":"Jain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana","family":"Rastogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherin S.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5801-9458","authenticated-orcid":false,"given":"Chhagan","family":"Bihari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2023.03.005_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0065-2776(08)60641-0","article-title":"Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology","volume":"44","author":"Tan","year":"1989","journal-title":"Adv Immunol"},{"key":"10.1016\/j.jceh.2023.03.005_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s13317-013-0046-7","article-title":"Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis","volume":"4","author":"Himoto","year":"2013","journal-title":"Auto Immun Highlights"},{"key":"10.1016\/j.jceh.2023.03.005_bib3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"International Autoimmune Hepatitis Group. Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.03.005_bib4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouill\u00e8res","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.03.005_bib5","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"Fan","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.03.005_bib6","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1572-0241.2004.30444.x","article-title":"The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease","volume":"99","author":"Adams","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2023.03.005_bib7","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2023.03.005_bib8","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1023\/B:DDAS.0000004522.36120.08","article-title":"Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates","volume":"48","author":"Loria","year":"2003","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2023.03.005_bib9","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1007\/s10620-015-3795-5","article-title":"Autoimmune markers do not impact clinical presentation or natural history of steatohepatitis-related liver disease","volume":"60","author":"Ravi","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2023.03.005_bib10","first-page":"1249","article-title":"Circulating antinuclear antibodies in patients with non-alcoholic steatohepatitis","volume":"409A","author":"Tumiel","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.03.005_bib11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12072-011-9277-8","article-title":"Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network","volume":"6","author":"Vuppalanchi","year":"2012","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2023.03.005_bib12","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1872-034X.2007.00150.x","article-title":"Clinicopathological significance of antinuclear antibodies in non-alcoholic steatohepatitis","volume":"37","author":"Niwa","year":"2007","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jceh.2023.03.005_bib13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/MPG.0000000000003534","article-title":"Autoimmune antibodies in children and adolescents with nonalcoholic fatty liver disease","volume":"75","author":"Kohut","year":"2022","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jceh.2023.03.005_bib14","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/hep.1840040505","article-title":"The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease","volume":"4","author":"Frei","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.03.005_bib15","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/hep4.1680","article-title":"Relationship of ELF and PIIINP with liver histology and response to vitamin E or pioglitazone in the PIVENS trial","volume":"5","author":"Gawrieh","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2023.03.005_bib16","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1111\/liv.14225","article-title":"Plasma N-terminal propeptide of type III procollagen accurately predicts liver fibrosis severity in children with non-alcoholic fatty liver disease","volume":"39","author":"Mosca","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2023.03.005_bib17","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1007\/s10620-016-4213-3","article-title":"Natural history of patients presenting with autoimmune hepatitis and coincident nonalcoholic fatty liver disease","volume":"61","author":"De Luca-Johnson","year":"2016","journal-title":"Dig Dis Sci"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688323000506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688323000506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:10:00Z","timestamp":1760854200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688323000506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0973688323000506"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2023.03.005","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibody Positivity Has No Impact on Histological Parameters in Nonalcoholic Fatty Liver Diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2023.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}